EnteroMedics Announces Food and Drug Administration Advisory Committee Meeting Date for Review of the Maestro(R) Rechargeable System for the Treatment of Obesity

[Marketwired] – EnteroMedics Inc. , the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. Food and Drug … more

View todays social media effects on ETRM

View the latest stocks trending across Twitter. Click to view dashboard

See who EnteroMedics is hiring next, click here to view